Sequencing razor-blade: sell the sequencer (NovaSeq X, now ~90% of research volume), monetize consumables forever. BIOSECURE tailwind reshoring demand to Western platforms.
Research snapshot · Not reviewed
ILMNIllumina
Sequencing platform + consumables
Open ILMN in Robinhood ↗Conviction●○○○○1 of 5
Research target—Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap28.55BSnapshot value
BIOSECURE OMB list (~Dec 2026) reshoring Chinese sequencing share; clinical sequencing shift (MRD, early detection, companion Dx); NovaSeq X Constellation bringing WGS to existing install base.
Roche Axelios/SBX launched July 2026 — first credible high-throughput threat in years; consumables pricing pressure (volume discounts); Ultima/Element ramping; Illumina-Grail unwind distraction.
needs X/Reddit sentiment sweep
Snapshot · Not reviewed🟡 Mixed · ins-$70.5M · 13F 11+/13- · short↓0.2
Snapshot · Not reviewed